CF LeMaistre - Concepedia

Author

CF LeMaistre

The University of Texas MD Anderson Cancer Center

Also Known As

C F LeMaistre, C F Lemaistre, C Fred Lemaistre, C LeMaistre, C.F LeMaistre, C.F. LeMaistre, C.F. Lemaistre, CF LeMaistre

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at San Antonio National Cancer Institute University of Nebraska Medical Center Palmetto Hematology Oncology

About

CF LeMaistre is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	299
2	Health Sciences	1	1	100
3	Blood Transplantation	1	1	24
4	Cell Biology	1	1	38
5	Cellular Therapies	1	1	100

CF LeMaistre

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study KG Blume, KJ Kopecky, JP Henslee-Downey, Blood	1993	162
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor CF LeMaistre, C Meneghetti, Michael G. Rosenblum, Blood	1992	157
Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides Mansoor N. Saleh, CF LeMaistre, Timothy M. Kuzel, Journal of the American Academy of Dermatology InflammationImmunologyPathologyImmunologic MechanismImmunopathology	1998	137
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor CF LeMaistre, C Meneghetti, Michael G. Rosenblum, Blood	1992	127
Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T- cell lymphoma CF LeMaistre, Steven T. Rosen, A Frankel, Blood	1991	116
Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid- resistant acute graft-versus-host disease VS Byers, P J Henslee, NA Kernan, Blood	1990	103
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma Pat Stiff, R. Gingrich, Selina M. Luger, Bone Marrow Transplantation Lymphoid NeoplasiaCell TherapyRandomized Phase 2Health SciencesMedicine	2000	100
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease Paul Shaughnessy, Carlos Bachier, Michael Grimley, Biology of Blood and Marrow Transplantation	2005	59
Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia CF LeMaistre, C Meneghetti, A. B. Deisseroth, The Lancet Hematological MalignancyChronic Lymphocytic LeukaemiaOncogenic AgentMalignant Blood DisorderImmunology	1991	38
Genetically identical twin transplantation for chronic lymphocytic leukemia Steven Z. Pavletic, Guowu Zhou, K. A. Sobocinski, Leukemia TransplantationMixed-phenotype Acute LeukemiaGeneticsImmunologyHematology	2007	24

Page 1